Manish Shah, MD, discusses avelumab’s effectiveness based on results from the JAVELIN 100 study

Manish Shah of Weill Cornell Medicine explains the results of a recent study in which gastric cancer patients given either chemo or the checkpoint inhibitor Bavencio (avelumab) as maintenance treatment did equally well.